Novel Antitubercular Agents Lead to a New Preclinical Candidate for VisceralLeishmaniasis. J. Med. Chem. 2017, 60, 10, 4212–4233. doi:10.1021/acs.jmedchem
Ejazi, SA; Ali, N. Developments in diagnosis and treatment of visceralleishmaniasis during the last decade and future prospects.. Expert review of anti-infective